Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-02-09
1986-03-11
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
2602393B, 2602393T, A61K 3155, C07D22316
Patent
active
045755035
ABSTRACT:
Variously substituted 1-carboxymethyl-3-(carboxymethylamino)-2,3,4,5-tetrahydro-1H-[1]benzazepin -2-ones and functional derivatives are angiotensin converting enzyme inhibitors and are useful as antihypertensive agents. Synthesis of, compositions and methods of treatment utilizing such compounds are included.
REFERENCES:
patent: 4410520 (1983-10-01), Watthey
patent: 4473575 (1984-09-01), Watthey
Derwent Abstract, 85-081046/13 (1985) of South African Patent Document 8303903 (Oct. 1, 1984).
Watthey, et al., 186th ACS National Meeting, Aug. 28-Sep. 2, 1983, Abstract No. 93.
Chen et al., The Pharmacologist, vol. 25, No. 3; (1983) CGS 14824A and CGS 14831.
Miller et al., The Pharmacologist, vol. 25, No. 3 (1983) CGS 14824A.
Parsons et al., Biochemical and Biophysical Research Communications 117, pp. 108-113 (1983).
Bond Robert T.
Ciba-Geigy Corporation
Gruenfeld Norbert
LandOfFree
3-Amino-[1]-benzazepin-2-one-1-alkanoic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191633